Trials / Unknown
UnknownNCT04475887
Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation (OLT) increases hemoglobin concentrations and reduces intraoperative transfusion of packed red blood cells (PRBCs). The investigators hypothesize that therapy with intravenous iron will increase hemoglobin concentrations and reduce intraoperative transfusion of PRBCs in patients with IDA listed for OLT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iron Carboxymaltose | see above |
| DRUG | Placebo | see above |
Timeline
- Start date
- 2020-07-23
- Primary completion
- 2022-12-31
- Completion
- 2023-05-31
- First posted
- 2020-07-17
- Last updated
- 2020-07-28
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04475887. Inclusion in this directory is not an endorsement.